Article
TMEM17 promotes malignant progression of breast cancer via AKT/GSK3β signaling
Cancer Management and Research · 2018 · Zhao Y, Song K, Zhang Y, Xu H, Zhang X, Wang L, Fan C, Jiang G, Wang E
Key facts
| Title | TMEM17 promotes malignant progression of breast cancer via AKT/GSK3β signaling |
|---|---|
| First author | Zhao Y, Song K, Zhang Y, Xu H, Zhang X, Wang L, Fan C, Jiang G, Wang E |
| Journal | Cancer Management and Research |
| Published | Aug 2, 2018 |
| DOI | 10.2147/CMAR.S168723 |
| Product codes mentioned | GIA |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1